Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Invesco Global Clean Energy ETF
PBD
$195M
| $96K | ﹤0.01% |
8,000
| – | – |
|
|
AERI
5227
DELISTED
Aerie Pharmaceuticals
AERI
| $96K | ﹤0.01% |
4,809
+4,625
| +2,514% | +$91.2K |
|
|
KIN
5228
DELISTED
Kindred Biosciences, Inc.
KIN
| $96K | ﹤0.01% |
10,666
+10,258
| +2,514% | +$139K |
|
|
NDRO
5229
DELISTED
Enduro Royalty Trust
NDRO
| $96K | ﹤0.01% |
8,770
-179
| -2% | -$2.36K |
|
|
GSIG
5230
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $96K | ﹤0.01% |
8,687
-7,476
| -46% | -$91.1K |
|
5231
Icahn Enterprises
IEP
$5.33B
| $95K | ﹤0.01% |
893
-3,481
| -80% | -$370K |
|
|
SHI
5232
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $95K | ﹤0.01% |
2,967
+1,258
| +74% | +$40.6K |
|
|
BT
5233
DELISTED
BT Group plc (ADR)
BT
| $95K | ﹤0.01% |
+3,100
| New | +$99.6K |
|
|
SNMX
5234
DELISTED
Senomyx, Inc.
SNMX
| $95K | ﹤0.01% |
11,762
-1,771
| -13% | -$14.1K |
|
|
LF
5235
CALL
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $95K | ﹤0.01% |
19,000
-56,300
| -75% | -$377K |
|
5236
PUT
A.O. Smith
AOS
$8.51B
| $94K | ﹤0.01% |
4,000
-200
| -5% | -$4.86K |
|
5237
CALL
AXIS Capital
AXS
$7.26B
| $94K | ﹤0.01% |
+2,000
| New | +$92.4K |
|
5238
Bank OZK
OZK
$5.69B
| $94K | ﹤0.01% |
3,007
+1,291
| +75% | +$41.6K |
|
5239
Rambus
RMBS
$10.8B
| $94K | ﹤0.01% |
7,846
-21,999
| -74% | -$278K |
|
5240
Steven Madden
SHOO
$3.49B
| $94K | ﹤0.01% |
4,449
-210,264
| -98% | -$4.71M |
|
5241
CALL
Unilever
UL
$135B
| $94K | ﹤0.01% |
2,044
+1,511
| +283% | +$74.6K |
|
|
CCXI
5242
DELISTED
ChemoCentryx, Inc.
CCXI
| $94K | ﹤0.01% |
23,536
+2,074
| +10% | +$11K |
|
|
HNR
5243
PUT
DELISTED
Harvest Natural Resources
HNR
| $94K | ﹤0.01% |
7,850
+1,250
| +19% | +$22.8K |
|
|
PBY
5244
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
| $94K | ﹤0.01% |
11,657
+5,215
| +81% | +$56.1K |
|
5245
CALL
Arcos Dorados Holdings
ARCO
$1.66B
| $93K | ﹤0.01% |
19,015
+7,195
| +61% | +$58.1K |
|
5246
CALL
Geron
GERN
$982M
| $93K | ﹤0.01% |
46,300
-16,545
| -26% | -$40.8K |
|
|
JBTM
5247
JBT Marel
JBTM
$6.15B
| $93K | ﹤0.01% |
3,384
+2,867
| +555% | +$82.5K |
|
5248
CALL
L3Harris
LHX
$54.1B
| $92K | ﹤0.01% |
1,400
-5,300
| -79% | -$375K |
|
5249
Main Street Capital
MAIN
$5.47B
| $92K | ﹤0.01% |
3,062
-10,486
| -77% | -$335K |
|
5250
ePlus
PLUS
$2.32B
| $92K | ﹤0.01% |
6,556
-10,316
| -61% | -$146K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.